Aandeel Pharming Group NL0010391025

quote:

Patrick78 schreef:

Volgens mij volgd IRIS Pharming niet eens!!

Gegroet,
Patrick.

quote:

roeland4 schreef:

LONDON, March 16 (newratings.com) - Analysts at Rabo Securities maintain their "outperform" rating on Pharming (PHG.BER). The target price is set to €7.

In a research note published yesterday, the analysts mention that the company has initiated the pre-clinical studies with recombinant human C1 inhibitor (rhC1INH) for certain cardiovascular and inflammatory diseases. The analyst expects Pharming to select one follow-on indication from the pre-clinical results for further development in the near future. The company's rhC1INH product for the treatment of hereditary angioedema is likely to be approved in Europe in the next 12 months.